Clodia Osipo
  • Associate Professor
  • Pathology
  • Microbiology and Immunology

Crosstalk between PKCalpha and Notch-4 in endocrine-resistant breast cancer cellsYun,J.; Pannuti,A.; Espinoza,I.; Zhu,H.; Hicks,C.; Zhu,X.; Caskey,M.; Rizzo,P.; D'Souza,G.; Backus,K.; Denning,M. F.; Coon,J.; Sun,M.; Bresnick,E. H.; Osipo,C.; Wu,J.; Strack,P. R.; Tonetti,D. A.; Miele,L.Oncogenesis 2013 ;2( ):e60

Evaluation of biomarkers in multifocal/multicentric invasive breast carcinomasPekmezci,M.; Szpaderska,A.; Osipo,C.; Ersahin,C.International Journal of Surgical Pathology 2013 ;21(2):126-132

The functional role of notch signaling in triple-negative breast cancerSpeiser,J. J.; Ersahin,C.; Osipo,C.Vitamins and hormones 2013 ;93( ):277-306

Gamma secretase inhibitors of Notch signalingOlsauskas-Kuprys,R.; Zlobin,A.; Osipo,C.OncoTargets and therapy 2013 ;6( ):943-955

The Effect of Cold Ischemia Time and/or Formalin Fixation on Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Results in Breast CarcinomaPekmezci,M.; Szpaderska,A.; Osipo,C.; Ersahin,C.Pathology research international 2012 ;2012( ):947041

NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implicationsClementz,A. G.; Rogowski,A.; Pandya,K.; Miele,L.; Osipo,C.Breast cancer research : BCR 2011 ;13(3):R63

Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence.Pandya,K.; Meeke,K.; Clementz,A. G.; Rogowski,A.; Roberts,J.; Miele,L.; Albain,K. S.; Osipo,C.British journal of cancer 2011 ;105(6):796-806

Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.Hao,L.; Rizzo,P.; Osipo,C.; Pannuti,A.; Wyatt,D.; Cheung,L. W.; Sonenshein,G.; Osborne,B. A.; Miele,L.Oncogene 2010 ;29(2):201-213

Trastuzumab resistance: role for Notch signalingMehta,K.; Osipo,C.Thescientificworldjournal 2009 ;9( ):1438-1448

Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancerRizzo,P.; Osipo,C.; Pannuti,A.; Golde,T.; Osborne,B.; Miele,L.Advances in Enzyme Regulation 2009 ;49(1):134-141

ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor.Osipo,C.; Patel,P.; Rizzo,P.; Clementz,A. G.; Hao,L.; Golde,T. E.; Miele,L.Oncogene 2008 ;27(37):5019-5032

Off the beaten pathway: the complex cross talk between Notch and NF-kappaB.Osipo,C.; Golde,T. E.; Osborne,B. A.; Miele,L. A.Laboratory Investigation 2008 ;88(1):11-17

Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approachesRizzo,P.; Miao,H.; D'Souza,G.; Osipo,C.; Song,L. L.; Yun,J.; Zhao,H.; Mascarenhas,J.; Wyatt,D.; Antico,G.; Hao,L.; Yao,K.; Rajan,P.; Hicks,C.; Siziopikou,K.; Selvaggi,S.; Bashir,A.; Bhandari,D.; Marchese,A.; Lendahl,U.; Qin,J. Z.; Tonetti,D. A.; Albain,K.; Nickoloff,B. J.; Miele,L.Cancer research 2008 ;68(13):5226-5235

Rational targeting of Notch signaling in cancerRizzo,P.; Osipo,C.; Foreman,K. E.; Golde,T.; Osborne,B.; Miele,L.Oncogene 2008 ;27(38):5124-5131

Intracellular distribution of TiO2-DNA oligonucleotide nanoconjugates directed to nucleolus and mitochondria indicates sequence specificityPaunesku,T.; Vogt,S.; Lai,B.; Maser,J.; Stojicevic,N.; Thurn,K. T.; Osipo,C.; Liu,H.; Legnini,D.; Wang,Z.; Lee,C.; Woloschak,G. E.Nano letters 2007 ;7(3):596-601

Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.Osipo,C.; Meeke,K.; Cheng,D.; Weichel,A.; Bertucci,A.; Liu,H.; Jordan,V. C.International journal of oncology 2007 ;30(2):509-520

Hedgehog signaling in hepatocellular carcinoma: novel therapeutic strategy targeting hedgehog signaling in HCCOsipo,C.; Miele,L.Cancer Biology & Therapy 2006 ;5(2):238-239

Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor alpha negative fulvestrant-resistant MCF-7 cellsLiu,H.; Cheng,D.; Weichel,A. K.; Osipo,C.; Wing,L. K.; Chen,B.; Louis,T. E.; Jordan,V. C.International journal of oncology 2006 ;29(5):1237-1246

Trastuzumab therapy for tamoxifen-stimulated endometrial cancerOsipo,C.; Meeke,K.; Liu,H.; Cheng,D.; Lim,S.; Weichel,A.; Jordan,V. C.Cancer research 2005 ;65(18):8504-8513

Reversal of tamoxifen resistant breast cancer by low dose estrogen therapyOsipo,C.; Gajdos,C.; Cheng,D.; Jordan,V. C.The Journal of steroid biochemistry and molecular biology 2005 ;93(2-5):249-256

MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosisLevenson,A. S.; Thurn,K. E.; Simons,L. A.; Veliceasa,D.; Jarrett,J.; Osipo,C.; Jordan,V. C.; Volpert,O. V.; Satcher,R. L.,Jr; Gartenhaus,R. B.Cancer research 2005 ;65(23):10651-10656

Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawalLewis,J. S.; Osipo,C.; Meeke,K.; Jordan,V. C.The Journal of steroid biochemistry and molecular biology 2005 ;94(1-3):131-141

The consequences of exhaustive antiestrogen therapy in breast cancer: estrogen-induced tumor cell deathOsipo,C.; Liu,H.; Meeke,K.; Jordan,V. C.Experimental biology and medicine (Maywood, N.J.) 2004 ;229(8):722-731

Changing role of the oestrogen receptor in the life and death of breast cancer cellsJordan,V. C.; Osipo,C.; Schafer,J. M.; Fox,J. E.; Cheng,D.; Liu,H.Breast (Edinburgh, Scotland) 2003 ;12(6):432-441

Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivoLiu,H.; Lee,E. S.; Gajdos,C.; Pearce,S. T.; Chen,B.; Osipo,C.; Loweth,J.; McKian,K.; De Los Reyes,A.; Wing,L.; Jordan,V. C.Journal of the National Cancer Institute 2003 ;95(21):1586-1597

Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancerOsipo,C.; Gajdos,C.; Liu,H.; Chen,B.; Jordan,V. C.Journal of the National Cancer Institute 2003 ;95(21):1597-1608

Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptorsOsipo,C.; Dorman,S.; Frankfater,A.Experimental cell research 2001 ;264(2):388-396